SyynX Social Networking and Discovery Applications Promote Scientific
Collaboration & Research
COLUMBIA, S.C. & COLOGNE, GERMANY, October 26 /CNW/ - Collexis Holdings,
Inc. (OTCBB: CLXS), a leading developer of high definition search and
discovery software, announced today that it has acquired its long-time
development partner, SyynX Solutions, a privately-held software company based
in Cologne, Germany.
For nearly a decade, Collexis and SyynX have collaborated on both a
technical and commercial level and the transaction is designed to combine the
respective strengths of each company. Recently, the two organizations
partnered to design the next generation in social networking, an online
platform for the life sciences community. The comprehensive system of
pre-populated expert profiles, coupled with the ability to analyze all
associated professional connections within the network, allows scientists and
researchers across multiple organizations to share data and collaborate in
ways never before considered.
SyynX software applications, based on the proprietary Collexis
Fingerprint technology, are already a valuable research tool employed globally
by organizations such as Johns Hopkins, the Mayo Clinic, Harvard University's
Dana Farber Cancer Institute and The National Institutes of Health.
"The SyynX software component is an ideal strategic complement to our
existing capabilities as the market leader in high-definition search and
discovery solutions," said Bill Kirkland, CEO of Collexis. "Our comprehensive
offerings address a growing market trend, as scientists are increasingly
recognizing the essential role that informatics, database and workflow
solutions play in more effectively managing research programs and driving
higher productivity. We believe that the acquisition of SyynX will position
Collexis as a global leader in providing these solutions, and our value
proposition to clients will be stronger as a result."
SyynX has been providing innovative knowledge solutions and text mining
applications to solve the unique challenges of the life science and healthcare
market since 1999, including: Merck Sharp & Dohme; the World Health
Organization (WHO - Alliance for Health Policy and Systems Research); BioSci
project (EMBO) and Asklepios Hospital Group, the largest privately held
healthcare system operating 100 hospitals in Germany and six in the United
States, where SyynX has implemented a comprehensive skills and knowledge
"After working together with the Collexis team for several years, the
SyynX team is more than excited about bringing the two companies together,"
said Christian Herzog, MD, CEO of SyynX Solutions. "The Collexis Fingerprint
core technology, combined with the applications built by SyynX, will provide a
great advantage to existing customers, as well as future ones."
"This formidable combination will enhance the world of knowledge
management, text and knowledge mining solutions not limited to the life
sciences market," said Martin Schmidt, Chief Technology Officer of SyynX. "The
strong potential of this corporate collaboration is perhaps most evident as we
prepare to launch our unprecedented social networking and collaboration
platform for the biomedical research community in early 2008. We believe that
this platform will change the way research is done."
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of High Definition Search
and Discovery software since 1999, is headquartered in Columbia, South
Carolina (USA) with operations in Geldermalsen, The Netherlands and, with the
acquisition of SyynX, in Cologne, Germany. Collexis' proprietary technology
builds conceptual profiles of text, called Fingerprints, from documents,
websites, e-mails and other digitized content and matches them with a
comprehensive list of pre-defined "fingerprinted" concepts to make research
results more relevant and efficient. This matching of concepts eliminates the
ambiguity and lack of priority associated with word searches. The results are
often described as "finding needles in many haystacks." Through this novel
approach, Collexis can build unique applications to search, index and
aggregate information as well as prioritize, trend and predict data based on
sources in multiple industries without the limitations of language or dialect.
Shares of Collexis common stock are traded under the symbol CLXS on the OTC
Bulletin Board (OTC BB). For more information, please visit www.collexis.com.
About SyynX Solutions GmbH
SyynX Solutions GmbH is a German software company focused on text
mining-based applications for the areas of life science and health care.
Collexis and SyynX have co-operated closely for nearly a decade on the
technical and commercial level. The SyynX applications based on the Collexis
Fingerprint technology are used by customers like universities, pharmaceutical
and biotech companies around the world. For more information, please visit
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties associated with the
acquisition of SyynX, with whether the benefits of the acquisition will occur
as anticipated, and with the planned launch of the company's social networking
and collaboration platform for the biomedical research community. These risks
and uncertainties are in addition to other factors detailed from time to time
in the company's filings with the SEC, including the section entitled "Risk
Factors" in its transition report on Form 10-KSB for the period ended June 30,
2007. The company cautions investors that any forward-looking statements made
by the company are not necessarily indicative of future performance. The
company is not responsible for updating the information contained in this
press release beyond the published date, or for changes made to this document
by wire services or Internet services.
For further information:
For further information: Avalanche Strategic Communications Denyse
Dabrowski, + 1-201-488-0049 Mobile: + 1-201-916-7122 email@example.com